Sarah Holte

6.6k total citations · 1 hit paper
107 papers, 5.0k citations indexed

About

Sarah Holte is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sarah Holte has authored 107 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Virology, 50 papers in Infectious Diseases and 19 papers in Epidemiology. Recurrent topics in Sarah Holte's work include HIV Research and Treatment (52 papers), HIV/AIDS Research and Interventions (49 papers) and HIV/AIDS drug development and treatment (24 papers). Sarah Holte is often cited by papers focused on HIV Research and Treatment (52 papers), HIV/AIDS Research and Interventions (49 papers) and HIV/AIDS drug development and treatment (24 papers). Sarah Holte collaborates with scholars based in United States, South Africa and Canada. Sarah Holte's co-authors include Ann C. Collier, Beryl A. Koblin, Lawrence Corey, James I. Mullins, Susan J. Little, Eric S. Daar, Michael L. Gross, Lei Wang, Jean‐Pierre Routy and Richard A. Koup and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Sarah Holte

105 papers receiving 4.9k citations

Hit Papers

Antiretroviral-Drug Resistance among Patients Recently In... 2002 2026 2010 2018 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
    2002 878 citations Susan J. Little, Sarah Holte et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Holte United States 35 2.8k 2.5k 1.2k 761 644 107 5.0k
Phyllis J. Kanki United States 40 3.5k 1.3× 3.6k 1.4× 1.7k 1.4× 1.2k 1.6× 431 0.7× 162 5.9k
John Bartlett United States 47 4.6k 1.7× 2.4k 1.0× 1.9k 1.6× 575 0.8× 484 0.8× 192 7.3k
Christopher D. Pilcher United States 43 4.5k 1.6× 3.5k 1.4× 2.3k 1.9× 502 0.7× 682 1.1× 100 5.9k
Richard Marlink United States 37 4.2k 1.5× 3.6k 1.4× 1.7k 1.4× 812 1.1× 565 0.9× 128 6.0k
Pontiano Kaleebu Uganda 36 3.0k 1.1× 2.5k 1.0× 1.2k 1.0× 742 1.0× 466 0.7× 266 4.9k
James O. Kahn United States 36 3.6k 1.3× 3.5k 1.4× 1.7k 1.4× 1.3k 1.8× 309 0.5× 70 5.8k
Rhoda Sperling United States 34 5.0k 1.8× 2.3k 0.9× 2.9k 2.4× 489 0.6× 1.2k 1.8× 96 7.8k
Tobias F. Rinke de Wit Netherlands 41 3.9k 1.4× 3.1k 1.2× 1.3k 1.1× 533 0.7× 644 1.0× 169 5.7k
Keith Henry United States 49 4.4k 1.6× 3.9k 1.5× 1.9k 1.5× 824 1.1× 274 0.4× 135 7.2k
Judith Feinberg United States 43 5.0k 1.8× 3.3k 1.3× 3.2k 2.6× 440 0.6× 351 0.5× 169 8.0k

Countries citing papers authored by Sarah Holte

Since Specialization
Citations

This map shows the geographic impact of Sarah Holte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Holte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Holte more than expected).

Fields of papers citing papers by Sarah Holte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Holte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Holte. The network helps show where Sarah Holte may publish in the future.

Co-authorship network of co-authors of Sarah Holte

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Holte. A scholar is included among the top collaborators of Sarah Holte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Holte. Sarah Holte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Kelsey A., Maggie S. Burhans, Jessica N. Kuzma, et al.. (2022). The impact of low-fat and full-fat dairy foods on symptoms of gastroesophageal reflux disease: an exploratory analysis based on a randomized controlled trial. European Journal of Nutrition. 61(5). 2815–2823. 7 indexed citations
2.
Mei, Yajun, et al.. (2022). Adaptive resources allocation CUSUM for binomial count data monitoring with application to COVID-19 hotspot detection. Journal of Applied Statistics. 50(14). 2889–2913. 1 indexed citations
3.
Bethancourt, Hilary J., Kelsey A. Schmidt, Maggie S. Burhans, et al.. (2022). Assessing the validity of plasma phospholipid fatty acids as biomarkers of dairy fat intake using data from a randomized controlled intervention trial. American Journal of Clinical Nutrition. 115(6). 1577–1588. 6 indexed citations
4.
Zhao, Yujie, Hao Yan, Sarah Holte, & Yajun Mei. (2021). Rapid detection of hot-spots via tensor decomposition with applications to crime rate data. Journal of Applied Statistics. 49(7). 1636–1662. 10 indexed citations
5.
Bull, Marta E., Sheila Styrchak, Jane Hitti, et al.. (2019). Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression. AIDS Research and Human Retroviruses. 35(6). 557–566. 2 indexed citations
6.
Kuzma, Jessica N., Derek Hagman, Kara L. Breymeyer, et al.. (2018). Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults. Cancer Epidemiology Biomarkers & Prevention. 28(3). 610–615. 13 indexed citations
7.
Bull, Marta E., Caroline M. Mitchell, Jaime Soria, et al.. (2018). Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation. AIDS. 32(11). 1389–1401. 12 indexed citations
8.
9.
Hecht, Frederick, Robert Wellman, Michael P. Busch, et al.. (2011). Identifying the Early Post-HIV Antibody Seroconversion Period. The Journal of Infectious Diseases. 204(4). 526–533. 13 indexed citations
10.
Graham, Susan M., Sarah Holte, Jason T. Kimata, Mark H. Wener, & Julie Overbaugh. (2009). A Decrease in Albumin in Early SIV Infection Is Related to Viral Pathogenicity. AIDS Research and Human Retroviruses. 25(4). 433–440. 3 indexed citations
11.
Stekler, Joanne D., Sarah Holte, Janine Maenza, et al.. (2008). HIV Dynamics in Seminal Plasma during Primary HIV Infection. AIDS Research and Human Retroviruses. 24(10). 1269–1274. 34 indexed citations
12.
13.
Ghee, Annette E, Kenneth Tapia, Sabina G. Astete, et al.. (2007). Sentinel Surveillance of Sexually Transmitted Infections/HIV and Risk Behaviors in Vulnerable Populations in 5 Central American Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 101–111. 92 indexed citations
14.
Graham, Susan M., Sarah Holte, Norbert Peshu, et al.. (2007). Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS. 21(4). 501–507. 109 indexed citations
15.
16.
Hladik, Florian, Anthony L. Desbien, Jean Lang, et al.. (2003). Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells. The Journal of Immunology. 171(5). 2671–2683. 47 indexed citations
17.
Malhotra, Uma, Sarah Holte, M. Michelle Berrey, et al.. (2001). Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. Journal of Clinical Investigation. 107(4). 505–517. 101 indexed citations
18.
Seage, George R., Sarah Holte, David S. Metzger, et al.. (2001). Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine?. American Journal of Epidemiology. 153(7). 619–627. 97 indexed citations
19.
Gross, Michael L., et al.. (2000). Feasibility of Chemoprophylaxis Studies in High Risk HIV-Seronegative Populations. AIDS Education and Prevention. 12(1). 71–78. 4 indexed citations
20.
Holte, Sarah & Michael Emerman. (2000). A competition model for viral inhibition of host cell proliferation. Mathematical Biosciences. 166(1). 69–84. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phyllis J. Kanki Breakdown of academic impact, for papers by John Bartlett Breakdown of academic impact, for papers by Christopher D. Pilcher Breakdown of academic impact, for papers by Richard Marlink Breakdown of academic impact, for papers by Pontiano Kaleebu Breakdown of academic impact, for papers by James O. Kahn Breakdown of academic impact, for papers by Rhoda Sperling Breakdown of academic impact, for papers by Tobias F. Rinke de Wit Breakdown of academic impact, for papers by Keith Henry Breakdown of academic impact, for papers by Judith Feinberg
Rankless by CCL
2026